Pulmagen Therapeutics Synergy Ltd.

Follow

Organization

Fulmer, Slough, GB

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Quinuclidine derivatives as muscarinic M3 receptor antagonists
- Patent number 8,329,729
- Issue date Dec 11, 2012
- Astrazeneca AB
- Richard James Bull
- C07 - ORGANIC CHEMISTRY